Satt IDF Innov has licenced research at Institut Cochin and Institut Pierre-Louis to SkinDemic, which will now commercialise a treatment for acne and Kaposi's sarcoma.

Satt IDF Innov, the regional tech transfer organisation for institutions in Ile-de-France, provided an exclusive licence to SkinDemic, a France-based dermatology spinout, last month, the office announced today.

SkinDermic was incorporated in 2017 to commercialise research into treatments for dermatological conditions by Nicolas Lupin and Philippe Grange from Institut Cochin and Vincent Calvez and Anne-Geneviève Marcelin from Institut Pierre-Louis.

The spinout is developing a therapy for inflammatory acne and for Kaposi’s sarcoma, a type of cancer that can form in…